Company History - Gujarat Themis Biosyn
Gujarat Themis Biosyn Ltd. was incorporated in 1981 jointly by GIIC
and chemosyn (P) Ltd. GIBL commenced production in Aug.1985 by
producing antibiotic erythromycin, and erythromycin salts and
formulations. GTBL was a sick company which was forced to
discontinue production because of accumulated losses. The company
was takenover during June 1991 by pharmaceutical Business Group India
Ltd; a unique consortium of five competing drug companies - Themis
Chemicals, Kopran, Anant & Co., Cadila and Lyka Labs. The company
has technical and financial collaboration with Yuhan Corporation,
South Korea. With Yuhan's knowhow, GTBL has become India's first
company to start commercial production of anti-tubercolis drug,
2002-Gujarat Themis Biosyn Ltd has informed that Mr Rajneesh Anand
has been appointed as the Managing Director of the Company w e f
February 01, 2002.
-Gujarat Themis Biosyn Ltd has appointed Mr. S S Lee as an Additional
Director of the Company.
-The Company has appointed Mr. Rajneesh Anand as Managing Director
- Gujarat Themis Biosyn Ltd has appointed Mr. Subhash C Kaushik as
Additional Director of the Company.
-The Board of Directors appointed Mr. Rajneesh Anand as Managing
Director of the Company
-The Company has received a Rehabilitation Scheme approved by the
Board of Industrial and Financial Reconstruction (BIFR)
-Mr. Vikas Tarekar has been appointed as a Company Secretary of the
-Mr. Tapas Guha has been appointed as a CEO of the Company.